Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.
J Clin Oncol
; 32(30): 3406-12, 2014 Oct 20.
Article
in En
| MEDLINE
| ID: mdl-25245446
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxides
/
Arsenicals
/
Quality of Life
/
Tretinoin
/
Leukemia, Promyelocytic, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2014
Document type:
Article